PRDM5过表达慢病毒载体的构建及稳定转染Neuro-2a细胞的建立

吴钊淳, 李友, 何嘉文, 廖科棋, 李胜男

PDF(1875 KB)
PDF(1875 KB)
吉林大学学报(医学版) ›› 2025, Vol. 51 ›› Issue (1) : 1-8. DOI: 10.13481/j.1671-587X.20250101
基础研究

PRDM5过表达慢病毒载体的构建及稳定转染Neuro-2a细胞的建立

作者信息 +

Construction of PRDM5 over-expression lentivirus vector and establishment of stably transfected Neuro-2a cells

Author information +
History +

摘要

目的 构建PR锌指区域蛋白(PRDM)5基因的过表达慢病毒载体,建立稳定转染的小鼠神经瘤母细胞Neuro-2a,为探讨PRDM5在缺血性脑卒中(IS)发病机制中的作用奠定基础。 方法 在NCBI上搜索PRDM5的序列并设计引物,PCR法扩增获取PRDM5基因序列,将其与BamHⅠ和AgeⅠ限制性内切酶双酶切后的慢病毒载体GV492进行连接,构建GV492-PRDM5过表达重组质粒,采用PCR法筛选并鉴定出的与目的基因片段长度相近的阳性克隆送生工生物工程(上海)股份有限公司测序。将测序正确的GV492-control质粒和GV492-PRDM5过表达重组质粒分别转染至人胚胎肾细胞HEK293T中,转染48 h后离心收集慢病毒,分别为GV492-control慢病毒和GV492-PRDM5过表达慢病毒,采用慢病毒滴度测定法检测上述2种慢病毒滴度。将Neuro-2a细胞分为GV492-control组和GV492-PRDM5组,分别使用GV492-control慢病毒和GV492-PRDM5过表达慢病毒感染Neuro-2a细胞,慢病毒感染复数(MOI)为100,感染72 h后使用嘌呤霉素(10 mg·L-1)对成功感染GV492-control慢病毒和GV492-PRDM5过表达慢病毒的Neuro-2a细胞进行筛选,通过荧光显微镜观察GV492-control组和GV492-PRDM5组Neuro-2a细胞的生长状态及绿色荧光蛋白的表达情况。采用实时荧光定量PCR(RT-qPCR)法检测2组Neuro-2a细胞中PRDM5 mRNA表达水平;Western blotting法检测2组Neuro-2a细胞中PRDM5蛋白表达水平。 结果 PCR法,GV492-PRDM5重组质粒阳性转化子的长度约为684 bp,GV492-PRDM5过表达重组质粒基因序列与设计合成的PRDM5过表达序列一致;GV492-control慢病毒和GV492-PRDM5过表达慢病毒的滴度均为2.5×108 TU·mL-1。荧光显微镜,GV492-control组和GV492-PRDM5组Neuro-2a细胞的生长状态均良好,且能观察到绿色荧光蛋白的表达。RT-qPCR法,与GV492-control组比较,GV492-PRDM5组Neuro-2a细胞中PRDM5 mRNA表达水平明显升高(P<0.01)。Western blotting法,GV492-control组和GV492-PRDM5组Neuro-2a细胞在相对分子质量为75 000附近出现特异性条带;与GV492-control组比较,GV492-PRDM5组Neuro-2a细胞中PRDM5蛋白表达水平升高(P<0.01)。 结论 成功构建PRDM5过表达慢病毒载体,建立了稳定转染的GV492-PRDM5-Neuro-2a细胞。

Abstract

Objective To construct the over-expressed lentivirus vector of PRDM5 gene and establish the Neuro-2a cells stably transfected PRDM5, and to provide the basis evidence for exploring the effect of PRDM5 in pathogenesis of ischemic stroke(IS). Methods The sequence of PRDM5 was searched and designed based on NCBI. The PRDM5 gene was amplified by PCR and ligated with the lentiviral vector GV492 digested by BamHⅠ and AgeⅠ restriction enzymes to form the GV492-PRDM5 over-expression recombinant plasmid. The positive clones with similar length and size to the target gene fragment were screened by PCR and sent to Shenggong Bioengineering (Shanghai) Co. Ltd. for identification. The correctly-sequenced GV492-control plasmid and GV492-PRDM5 over-expression recombinant plasmid were transfected into the HEK293T cells, respectively. After 48 h of transfection, the lentiviruses were collected by centrifugation, and they were GV492-control lentivirus and GV492-PRDMS over-expression lentivirus; the titers of these two lentiviruses were determined by lentiviral titer assay. The Neuro-2a cells were divided into GV492-control group and GV492-PRDM5 group, and then infected with GV492-control lentivirus and GV492-PRDM5 over-expression lentivirus, respectively, with a lentivirus multiplicity of infection (MOI) of 100. The Neuro-2a cells successfully infected with GV492-control lentivirus and GV492-PRDM5 over-expression lentivirus were screened with puromycin (10 mg·L-1) after 72 h of infection. The growth status and the expression of green fluorescence protein of Neuro-2a cells in GV492-control group and GV492-PRDM5 group were observed by fluorescence microscope. The expression levels of PRDM5 mRNA and PRDM5 protein in the Neuro-2a cells in two groups were detected by real-time fluorescence quantitative RCR(RT-qPCR) and Western blotting methods. Results The PCR results showed that the length of the positive transformant of GV492-PRDM5 recombinant plasmid was about 684 bp, and the gene sequence of GV492-PRDM5 over-expression recombinant plasmid was consistent with the designed and synthesized PRDM5 over-expression sequence. The titers of GV492-control lentivirus and GV492-PRDM5 over-expression lentivirus were both 2.5×108 TU·mL-1. The Neuro-2a cells in GV492-control group and GV492-PRDM5 group grew well, and the expressions of green fluorescence protein were found under fluorescence microscope.The RT-qPCR results showed that the expression level of PRDM5 mRNA in the Neuro-2a cells in GV492-PRDM5 group was significantly increased compared with GV492-control group(P<0.01). The Western blotting results showed that the specific bands appeared in the Neuro-2a cells in GV492-control group and GV492-PRDM5 group with a relative molecular weight of 75 000; compared with GV492-control group, the expression level of PRDM5 protein in the Neuro-2a cells in GV492-PRDM5 group was increased(P<0.01). Conclusion The over-expression lentivirus vector of PRDM5 gene is successfully constructed, and the stably transfected GV492-PRDM5-Neuro-2a cells are established.

关键词

PR锌指区域蛋白 / 过表达慢病毒载体 / 稳定表达 / Neuro-2a细胞

Key words

PRDI-BF1 and RIZ domain proteins / Over-expression lentivirus vector / Stable expression / Neuro-2a cells

中图分类号

R543.5

引用本文

导出引用
吴钊淳 , 李友 , 何嘉文 , . PRDM5过表达慢病毒载体的构建及稳定转染Neuro-2a细胞的建立. 吉林大学学报(医学版). 2025, 51(1): 1-8 https://doi.org/10.13481/j.1671-587X.20250101
Zhaochun WU, You LI, Jiawen HE, et al. Construction of PRDM5 over-expression lentivirus vector and establishment of stably transfected Neuro-2a cells[J]. Journal of Jilin University(Medicine Edition). 2025, 51(1): 1-8 https://doi.org/10.13481/j.1671-587X.20250101

参考文献

1
DI TULLIO F SCHWARZ M ZORGATI H, et al. The duality of PRDM proteins: epigenetic and structural perspectives[J]. FEBS J2022289(5): 1256-1275.
2
LESZCZYŃSKI P ŚMIECH M PARVANOV E, et al. Emerging roles of PRDM factors in stem cells and neuronal system: cofactor dependent regulation of PRDM3/16 and FOG1/2 (novel PRDM factors)[J]. Cells20209(12): 2603.
3
CASAMASSIMI A RIENZO M DI ZAZZO E, et al. Multifaceted role of PRDM proteins in human cancer[J]. Int J Mol Sci202021(7): 2648.
4
MEHMOOD S, DAD R, AHMAD A, et al. Structural and functional annotation of PR/SET domain (PRDM) protein family: in-silico study elaborating role of PRDM12 mutation in congenital insensitivity to pain[J]. Comput Biol Chem202089: 107382.
5
LIU J WU W J HAO J, et al. PRDM5 expression and essential role after acute spinal cord injury in adult rat[J]. Neurochem Res201641(12): 3333-3343.
6
DUAN Z J PERSON R E LEE H H, et al. Epigenetic regulation of protein-coding and microRNA genes by the Gfi1-interacting tumor suppressor PRDM5[J]. Mol Cell Biol200727(19): 6889-6902.
7
DENG Q D HUANG S. PRDM5 is silenced in human cancers and has growth suppressive activities[J]. Oncogene200423(28): 4903-4910.
8
TAN S X HU R C TAN Y L, et al. Promoter methylation-mediated downregulation of PRDM5 contributes to the development of lung squamous cell carcinoma[J]. Tumour Biol201435(5): 4509-4516.
9
WANG L DING Q Q GAO S S, et al. PRDM5 promotes the proliferation and invasion of murine melanoma cells through up-regulating JNK expression[J]. Cancer Med20165(9): 2558-2566.
10
ZHOU P CHEN X LI M K, et al. Overexpression of PRDM5 promotes acute myeloid leukemia cell proliferation and migration by activating the JNK pathway[J]. Cancer Med20198(8): 3905-3917.
11
GUO X L CHEN H LI S N, et al. LncRNA MALAT1 promotes neuronal apoptosis during spinal cord injury through miR-199a-5p/PRDM5 axis[J]. Turk Neurosurg202434(2): 196-205.
12
ZHANG Y WANG S S LI H L, et al. MiR-495 reduces neuronal cell apoptosis and relieves acute spinal cord injury through inhibiting PRDM5[J]. J Mol Histol202152(2): 385-396.
13
ZHANG H F WANG W G LI N, et al. LncRNA DGCR5 suppresses neuronal apoptosis to improve acute spinal cord injury through targeting PRDM5[J]. Cell Cycle201817(16): 1992-2000.
14
ZHANG Y LIU X J XUE H Q, et al. Upregulation of PRDM5 is associated with astrocyte proliferation and neuronal apoptosis caused by lipopolysaccharide[J]. J Mol Neurosci201659(1): 146-157.
15
SARVARI S MOAKEDI F HONE E, et al. Mechanisms in blood-brain barrier opening and metabolism-challenged cerebrovascular ischemia with emphasis on ischemic stroke[J]. Metab Brain Dis202035(6): 851-868.
16
FESKE S K. Ischemic stroke[J]. Am J Med2021134(12): 1457-1464.
17
JOLUGBO P ARIËNS R A S. Thrombus composition and efficacy of thrombolysis and thrombectomy in acute ischemic stroke[J]. Stroke202152(3): 1131-1142.
18
HERPICH F RINCON F. Management of acute ischemic stroke[J]. Crit Care Med202048(11): 1654-1663.
19
RABINSTEIN A A. Update on treatment of acute ischemic stroke[J]. Continuum202026(2): 268-286.
20
LING W Q XU X LIU J B. A causal relationship between the neurotherapeutic effects of miR182/7a and decreased expression of PRDM5[J]. Biochem Biophys Res Commun2017490(1): 1-7.
21
ZHANG H F LI D Z ZHANG Y, et al. Knockdown of lncRNA BDNF-AS suppresses neuronal cell apoptosis via downregulating miR-130b-5p target gene PRDM5 in acute spinal cord injury[J]. RNA Biol201815(8): 1071-1080.
22
LI S N CHEN S F WANG Y J, et al. Direct targeting of DOCK4 by miRNA-181d in oxygen-glucose deprivation/reoxygenation-mediated neuronal injury[J]. Lipids Health Dis202322(1): 34.
23
SHARMA A BRENNER M JACOB A, et al. Extracellular CIRP activates the IL-6Rα/STAT3/Cdk5 pathway in neurons[J]. Mol Neurobiol202158(8): 3628-3640.
24
ZHANG G L GUO J H ZENG J, et al. LncRNA SNHG14 is beneficial to oxygen glucose deprivation/reoxygenation-induced neuro-2a cell injury via mir-98-5p sequestration-caused BCL2L13 upregulation[J]. Metab Brain Dis202237(6): 2005-2016.
25
DONG W CHEN Q F ZHAO S Y, et al. IKKα contributes to ischemia-induced autophagy after acute cerebral ischemic injury[J]. Ann Transl Med202210(4): 160.
26
COCKRELL A S KAFRI T. Gene delivery by lentivirus vectors[J]. Mol Biotechnol200736(3): 184-204.

作者贡献声明

吴钊淳参与实验过程和论文撰写,作者贡献声明:

李友、何嘉文和廖科棋参与实验过程,李胜男参与实验的整体设计和论文审校。

基金

国家自然科学基金项目(81571157)
广东省基础与应用基础研究基金委员会自然科学基金面上项目(2023A1515012750)
广东省卫健委医学科研基金项目(A2022139)
广东医科大学百项青年研究项目资助计划项目(GDMUD2022010)

版权

©《吉林大学学报(医学版)》编辑部,开放获取遵循CC BY-NC-ND协议。

评论

PDF(1875 KB)

Accesses

Citation

Detail

段落导航
相关文章

/